Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly Monosomy 5. (A cytogenetic aneuploidy abnormality that refers to the presence of one chromosome 5 only. It is associated with the development of refractory anemia with excess blasts, refractory anemia with multilineage dysplasia, and refractory anemia with multilineage dysplasia and ringed sideroblasts.)
Biomarker and diagnostic research for acute myeloid leukemia, Monosomy 5 has been reported in the published literature.
No clinical trials have been registered for acute myeloid leukemia, Monosomy 5.
31 publications have been identified in PubMed for acute myeloid leukemia, Monosomy 5. Research spans Basic Science / Preclinical (26%), Epidemiology / Natural History (23%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 8 | 26% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 6:51 AM UTC
Common questions about acute myeloid leukemia, Monosomy 5
Disease patterns and progression
7 |
23% |
Testing and diagnosis research | 5 | 16% |
Patient case studies | 5 | 16% |
Research summaries | 3 | 10% |
Clinical study results | 2 | 6% |
New treatment approaches | 1 | 3% |
Yokoyama H (2026). [PMID: 41493720](https://pubmed.ncbi.nlm.nih.gov/41493720/). *Int J Hematol*. [Diagnostic / Biomarker]
Hamilton RM (2026). [PMID: 41635182](https://pubmed.ncbi.nlm.nih.gov/41635182/). *Cytometry A*. [Diagnostic / Biomarker]
Spinella JF (2026). [PMID: 42139355](https://pubmed.ncbi.nlm.nih.gov/42139355/). *Sci Adv*. [Basic Science / Preclinical]
Niscola P (2025). [PMID: 39950462](https://pubmed.ncbi.nlm.nih.gov/39950462/). *Cardiovasc Hematol Agents Med Chem*. [Case Report / Case Series]
Kugler E (2025). [PMID: 40164144](https://pubmed.ncbi.nlm.nih.gov/40164144/). *Leuk Lymphoma*. [Basic Science / Preclinical]
Matsumoto Y (2025). [PMID: 39969773](https://pubmed.ncbi.nlm.nih.gov/39969773/). *Int J Hematol*. [Epidemiology / Natural History]
Liu L (2025). [PMID: 40646469](https://pubmed.ncbi.nlm.nih.gov/40646469/). *BMC Cancer*. [Diagnostic / Biomarker]
Huang X (2025). [PMID: 40512417](https://pubmed.ncbi.nlm.nih.gov/40512417/). *Clin Exp Med*. [Diagnostic / Biomarker]
Abunaser SMA (2025). [PMID: 40925076](https://pubmed.ncbi.nlm.nih.gov/40925076/). *Cancer Genet*. [Case Report / Case Series]
Kotmayer L (2025). [PMID: 40568716](https://pubmed.ncbi.nlm.nih.gov/40568716/). *Haematologica*. [Review / Meta-Analysis]